Drug Discovery – Page 3

Iambic Therapeutics Enhances AI Suite with “Enchant” for Predictive Preclinical Drug Development

6 months ago talkbio0Tagged Aortic Valve Insufficiency, Artificial Intelligence, clinical success, Drug Discovery, Enchant, Iambic, preclinical predictive powers, Prediction

Iambic Therapeutics, AI, Enchant, preclinical predictive powers, drug discovery, clinical success prediction

FogPharma Rebrands to Parabilis Medicines, Emphasizing AI-Driven Drug Discovery

6 months ago talkbio0Tagged Aortic Valve Insufficiency, capabilities, Drug Discovery, FogPharma, Parabilis Medicines, rebranding

FogPharma, Parabilis Medicines, AI capabilities, drug discovery, rebranding

Terray Therapeutics Secures $120M Series B Funding to Advance AI-Driven Small Molecule Drug Development

6 months ago talkbio0Tagged Biotechnology, Drug Discovery, pharmaceutical innovation, small molecule development, Terray Therapeutics

AI-driven drug discovery, small molecule development, Terray Therapeutics, series B funding, biotechnology, pharmaceutical innovation.

Pfizer and Triana Biomedicines Collaborate on Molecular Glue Discovery for Cancer and Other Diseases in $1.5 Billion Deal

6 months ago talkbio0Tagged Biotechnology, Drug Discovery, molecular glue, Neoplasms, Pfizer, Triana Biomedicines

Pfizer, Triana Biomedicines, molecular glue, cancer, oncology, drug discovery, biotechnology, pharmaceuticals

Eli Lilly and insitro Collaborate on AI-Driven Metabolic Disease Therapies

7 months ago talkbio0Tagged Aortic Valve Insufficiency, Artificial Intelligence, Biotechnology, Drug Discovery, Eli, Eli Lilly, GalNAc, Insitro, Metabolic Diseases, pharmaceutical partnership, RNA, Small Interfering

Eli Lilly, insitro, AI, metabolic diseases, siRNA, GalNAc, drug discovery, biotechnology, pharmaceutical partnership

Septerna Embarks on IPO Journey with Promising Preclinical Data and Vision to Revolutionize GPCR Drug Discovery

7 months ago talkbio0Tagged agonists, Biotechnology, Drug Discovery, G-Protein-Coupled Receptors, Hypoparathyroidism, IPO, Preclinical, PTH1R gene, Septerna

Septerna, IPO, GPCR, preclinical data, drug discovery, biotechnology, PTH1R agonists, hypoparathyroidism

Revolutionizing Drug Discovery: AI-Driven Solutions for Efficient and Personalized Treatments

7 months ago talkbio0Tagged Artificial Intelligence, Computation (action), Drug Development, Drug Discovery, Efficient, Identification (Psychology), Machine Learning, Machine Learning, Pharmaceutical Research, Precision Medicine, processes, QML, quantum, Quantum Machine Learning, Target, Validation

Artificial Intelligence (AI) in Drug Discovery, Machine Learning (ML) for Drug Development, Quantum Computing in Pharmaceutical Research, Personalized Medicine, Efficient Drug Discovery Processes, AI-Driven Target Identification and Validation, Quantum Machine Learning (QML) for Drug Discovery